Biocon Biologics, Voluntis collaborate for digital therapeutics for diabetics patients Ruchika Sharma22 July 2020 1:22 PM ISTNew Delhi: Biocon Biologics on Tuesday announced a global collaboration agreement with Voluntis to develop and distribute digital therapeutics...
Covid-19 Vaccine: Draw up immunization strategy now itself, says Biocon Chief Kiran Mazumdar-Shaw Ruchika Sharma21 July 2020 2:43 PM ISTBengaluru: India needs to draw up its immunization strategy now itself on the administration of the vaccine for COVID-19 on the population when it...
CONTROVERSY: DCGI exempts Biocon from Phase 3 trial of COVID drug Itolizumab, ICMR sees red Farhat Nasim17 July 2020 4:21 PM ISTBengaluru: In a major controversy, the exemption of biotechnology major Biocon from conducting Phase 3 trials of its psoriasis drug...
Biocon Itolizumab gets DCGI nod to treat COVID-19 patients Ruchika Sharma13 July 2020 1:28 PM ISTItolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru.
Biocon to invest over Rs 1493 crore capex for current fiscal Ruchika Sharma4 July 2020 1:40 PM ISTThe capex will be funded through a combination of contribution from internal accruals, debt raise as well as an additional private equity investment...
Biocon Chief condemns ICMR for not permitting Asymptomatic Testing Ruchika Sharma27 Jun 2020 11:55 AM ISTBengaluru: Biotechnology industry veteran Kiran Mazumdar-Shaw on Friday criticised the Indian Council of Medical Research for "not permitting"...
Biocon, DKSH ink pact to commercialize 7 generic formulations in Singapore, Thailand Ruchika Sharma23 Jun 2020 1:08 PM ISTUnder the terms of the agreement, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various...
